Clinical Trial Update: The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether synovial biopsy findings can predict response to biologic therapy in rheumatoid arthritis, which has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Abu Dhabi Stem Cells Center | Conditions: Rheumatoid Arthritis | Phase 3 | Status: WITHDRAWN